MGEN - miRagen Therapeutics Inc. (MGEN) CEO Bill Marshall on Q1 2019 Results - Earnings Call Transcript
miRagen Therapeutics, Inc. (MGEN)
Q1 2019 Results Earnings Conference Call
May 08, 2019 04:30 PM ET
Company Participants
Dan Ferry - LifeSci Advisors
Bill Marshall - President and Chief Executive Officer
Jason Leverone - Chief Financial Officer
Paul Rubin - Executive Vice President of Research and Development
Adam Levy - Chief Business Officer
Conference Call Participants
Jonathan Miller - Evercore ISI
Liana Moussatos - Wedbush Securities
Eun Yang - Jefferies
Madhu Kumar - Robert W. Baird
George Zavoico - B. Riley FBR
Presentation
Operator
Greetings, and welcome to the miRagen Therapeutics First Quarter 2019 Earnings